Next Stage: The challenges and pivots required to innovate in clinical drug discovery: a feline story:

Cat Health Corp. pursued a non-traditional multi-API drug strategy, overcoming investor resistance and building a faster path to clinic by leveraging existing compounds and novel combinations. This session will explore why unconventional drug models face pushback, how existing molecules can accelerate development timelines, and what founders need to do to bring investors along on non-traditional strategies.